Gallstone Disease
18
6
6
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
5.6%
1 terminated out of 18 trials
88.9%
+2.4% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (18)
Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice
Gut Microbiome and Metabolome in Patients With Gallstone Disease After Surgical and Endoscopic Interventions
Transabdominal and Laparoscopic Ultrasound in a Bariatric Setting
Pharmacokinetics, Bioequivalence, and Safety Study of Trimedat® 76,95 mg Orally Disintegrating Tablets and Trimedat® 100 mg Tablets in Healthy Volunteers.
EULAT Eradicate GBC
Endoscopic Antegrade Sphincterotomy (ASD) Versus Standard Sphincterotomy
TENS for Anxiety, Pain, and Satisfaction After Laparoscopic Cholecystectomy
GallRiks ERC Anesthesia Study
Prevention of NAFLD and CVD Through Lifestyle Intervention
A Randomized Controlled Trial Comparing Fat-free Versus Balanced (WHO) Diet in Gallstone Disease
MicroRNAs as Bile-based Biomarkers in Pancreaticobiliary Cancers
Gallbladder Infundibulum as a Guide for Ductal Identification.
Systems Biology of Gastrointestinal and Related Diseases
Radiological Investigation of Bile Duct Obstruction
Multimedia Informed Consent & PROMs in Laparoscopic Cholecystectomy
Effects of Calot's Triangle Block for Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy: a Prospective, Randomized, Double-blind, Controlled, Clinical Trial
Comparing Minilaparotomy and Laparoscopic Cholecystectomy as a Day Surgery Procedure
Technical Feasibility of Routine Intraoperative Cholangiography During Elective Rigid-hybrid Transvaginal Natural Orifice Transluminal Endoscopic Cholecystectomy